Current portfolio

Merus

Innovative full-length bispecific and trispecific antibody therapeutics for oncology.

  • Sektor
    Healthcare
  • Land
    Netherlands
  • Fond
    LSP 4
  • Entry
    2010
  • Web
Logo

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180